“The world is in a new and dangerous phase. Many people are understandably fed up with being at home. Countries are understandably eager to open up their societies and economies. But the virus is still spreading fast, it’s still deadly, and most people are still susceptible,” said Tedros on June 19.
“More than 8.8 million cases have now been reported to WHO, and more than 465,000 people have lost their lives,” Tedros said.
Arguing that measures taken to protect against the pandemic should not be a choice between human lives and livelihoods, Tedros said countries can do both, but warned that many countries that had suppressed the virus were seeing an upswing in cases as the countries reopened.
“We urge countries to be careful and creative in finding solutions that enable people to stay safe while getting on with their lives. We continue to urge all countries to double down on the fundamental public health measures that we know work,” he said.
WHO Supports New Drug For Treating the COVID-19 Pathogen
Tedros also declared that the WHO was now recommending the use of the steroid dexamethasone for the treatment of critically ill COVID-19 patients.“This is great news, and I congratulate the government of the UK, the University of Oxford, and the many hospitals and patients in the UK who have contributed to this lifesaving scientific breakthrough.”
Dexamethasone is an anti-inflammatory drug that has been in use since the 1960s. It decreases the body’s natural defensive response to swelling and allergic-type reactions and is often used to treat conditions like arthritis, immune system disorders, asthma, and certain cancers.